Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen

Clinical trial NCT03081910 · RECRUITING

Trial details

NCT number: NCT03081910
Sponsor: Baylor College of Medicine
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

T-cell Acute Lymphoblastic Lymphoma T-non-Hodgkin Lymphoma T-cell Acute Lymphoblastic Leukemia

Start date: 2017-11-01
Primary completion: 2028-06-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.